Impacting the Prescribing of Opioids through Academic Detailing
通过学术细节影响阿片类药物的处方
基本信息
- 批准号:10022296
- 负责人:
- 金额:$ 76.88万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-30 至 2021-09-29
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
1 Academic detailing (AD) programs that educate providers on the appropriate prescribing of opioids have the
2 potential to improve health outcomes and patient care, but the extent to which AD is effective for this purpose
3 is not well established. The long-term goal of the proposed research is to improve the management of
4 patients with chronic pain while reducing fatal and non-fatal opioid overdoses. This goal will be accomplished
5 by implementing and evaluating AD programs delivered to primary care providers on the appropriate
6 management of chronic non-cancer pain. The objective is to improve appropriateness of opioid prescribing by
7 primary care providers in Illinois. The central hypothesis is that one-on-one AD visits by academic detailers
8 will improve appropriate opioid prescribing by primary care providers and enhance their use of the State
9 Prescription Drug Program (PMP). The rationale for the proposed research is rooted in the need to generate
10 evidence on the effectiveness of AD programs to improve opioid prescribing and provide resources to
11 successfully implement them. This work will be accomplished by building on pilot AD programs in the
12 Chicagoland and Southern Illinois regions that we successfully implemented in collaboration with the State of
13 Illinois PMP. The proposed research will rigorously evaluate the effectiveness of two different AD programs in
14 Illinois. The specific aims are: 1) to evaluate the short-term (6 month) impact of an AD program involving 2
15 visits on opioid prescribing patterns and PMP utilization among primary care providers; 2) to determine the
16 longer-term effectiveness (12 months) of a more sustained AD program (i.e. more than two visits); 3) to
17 develop an online toolkit of accessible resources for AD programs on the safe and appropriate management of
18 patients with chronic pain for use by health-systems and state/local health departments. The proposed
19 research is innovative in the design of the AD visit on opioid prescribing, including individualized opioid
20 metrics that compare provider prescribing to local norms using Illinois PMP data, use of validated measures to
21 assess intention to change opioid prescribing behavior as a result of the AD visit, and program evaluation
22 using a stepped-wedge cluster-randomized design. Our successful experience in implementing pilot AD
23 programs in the state as part of Illinois' CDC prevention for states activities and our established relationship
24 with the Illinois PMP and health-systems throughout Illinois make us well positioned to evaluate the impact of
25 AD on opioid prescribing activities. The proposed research is significant to combating the opioid epidemic
26 because evidence to support the effectiveness of AD programs and their design and delivery is critical to
27 identifying approaches that modify prescribing behaviors and improve the management of patients with pain.
28 The expected outcome is to positively impact clinical decision-making and patient outcomes in Illinois and
29 address evidence gaps on the effectiveness of AD programs that leverage relationships with state PMPs to
30 improve opioid prescribing and pain management by healthcare providers.
1 .学术详细(AD)计划教育提供者适当开具阿片类药物处方
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ALAN SIMON PICKARD其他文献
ALAN SIMON PICKARD的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ALAN SIMON PICKARD', 18)}}的其他基金
Impacting the Prescribing of Opioids through Academic Detailing
通过学术细节影响阿片类药物的处方
- 批准号:
9905943 - 财政年份:2019
- 资助金额:
$ 76.88万 - 项目类别:
Impacting the Prescribing of Opioids through Academic Detailing
通过学术细节影响阿片类药物的处方
- 批准号:
10339309 - 财政年份:2019
- 资助金额:
$ 76.88万 - 项目类别:
Proxy Perspective on Quality of Life in Prostate Cancer
前列腺癌生活质量的代理视角
- 批准号:
6880100 - 财政年份:2004
- 资助金额:
$ 76.88万 - 项目类别:
Proxy Perspective on Quality of Life in Prostate Cancer
前列腺癌生活质量的代理视角
- 批准号:
6796054 - 财政年份:2004
- 资助金额:
$ 76.88万 - 项目类别:
相似海外基金
Prescribing of opioids at hospital discharge and associated adverse patient outcomes
出院时阿片类药物的处方和相关的不良患者结局
- 批准号:
10225290 - 财政年份:2019
- 资助金额:
$ 76.88万 - 项目类别:
Prescribing of opioids at hospital discharge and associated adverse patient outcomes
出院时阿片类药物的处方和相关的不良患者结局
- 批准号:
10459305 - 财政年份:2019
- 资助金额:
$ 76.88万 - 项目类别:
Prescribing of opioids at hospital discharge and associated adverse patient outcomes
出院时阿片类药物的处方和相关的不良患者结局
- 批准号:
10018914 - 财政年份:2019
- 资助金额:
$ 76.88万 - 项目类别:
Prescribing of opioids at hospital discharge and associated adverse patient outcomes
出院时阿片类药物的处方和相关的不良患者结局
- 批准号:
10668243 - 财政年份:2019
- 资助金额:
$ 76.88万 - 项目类别:
Impacting the Prescribing of Opioids through Academic Detailing
通过学术细节影响阿片类药物的处方
- 批准号:
9905943 - 财政年份:2019
- 资助金额:
$ 76.88万 - 项目类别:
Impacting the Prescribing of Opioids through Academic Detailing
通过学术细节影响阿片类药物的处方
- 批准号:
10339309 - 财政年份:2019
- 资助金额:
$ 76.88万 - 项目类别:
SPOiLER: towards Safer Prescribing of Legal Opioids from the Emergency Room
剧透:在急诊室更安全地开出合法阿片类药物
- 批准号:
10364730 - 财政年份:2018
- 资助金额:
$ 76.88万 - 项目类别:
SPOiLER: towards Safer Prescribing of Legal Opioids from the Emergency Room
剧透:在急诊室更安全地开出合法阿片类药物
- 批准号:
10116352 - 财政年份:2018
- 资助金额:
$ 76.88万 - 项目类别:
Perinatal maternal opioid use: Exploring prescribing trends, and the maternal and neonatal safety of postpartum opioids using administrative data
围产期孕产妇阿片类药物使用:利用管理数据探索产后阿片类药物的处方趋势以及孕产妇和新生儿安全性
- 批准号:
406746 - 财政年份:2018
- 资助金额:
$ 76.88万 - 项目类别:
Studentship Programs
Dental prescribing of antibiotics and opioids: high use in the absence of evidence
抗生素和阿片类药物的牙科处方:在缺乏证据的情况下大量使用
- 批准号:
9753146 - 财政年份:2017
- 资助金额:
$ 76.88万 - 项目类别: